Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Maximizing the impact of the Cures Acceleration Network : accelerating the development of new drugs and diagnostics : workshop summary / / Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
| Maximizing the impact of the Cures Acceleration Network : accelerating the development of new drugs and diagnostics : workshop summary / / Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies |
| Pubbl/distr/stampa | Washington, District of Columbia : , : National Academies Press, , [2012] |
| Descrizione fisica | 1 online resource (132 p.) |
| Disciplina | 615.1/9 |
| Soggetto topico |
Drug monitoring
Drug development - United States Drugs - United States - Design Pharmaceutical industry - United States - Quality control |
| Soggetto genere / forma | Electronic books. |
| ISBN | 0-309-26117-1 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction [The history and goals of CAN (Cures Acceleration Network)] -- Approaches to accelerating translational science -- Application of matching authority -- Application of flexible research authority -- Situating CAN within the drug development ecosystem -- Final reflections on ways to maximize the goals of CAN. |
| Record Nr. | UNINA-9910463950903321 |
| Washington, District of Columbia : , : National Academies Press, , [2012] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Maximizing the impact of the Cures Acceleration Network : accelerating the development of new drugs and diagnostics : workshop summary / / Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
| Maximizing the impact of the Cures Acceleration Network : accelerating the development of new drugs and diagnostics : workshop summary / / Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies |
| Pubbl/distr/stampa | Washington, District of Columbia : , : National Academies Press, , [2012] |
| Descrizione fisica | 1 online resource (132 p.) |
| Disciplina | 615.1/9 |
| Soggetto topico |
Drug monitoring
Drug development - United States Drugs - United States - Design Pharmaceutical industry - United States - Quality control |
| ISBN |
0-309-26119-8
0-309-26117-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction [The history and goals of CAN (Cures Acceleration Network)] -- Approaches to accelerating translational science -- Application of matching authority -- Application of flexible research authority -- Situating CAN within the drug development ecosystem -- Final reflections on ways to maximize the goals of CAN. |
| Record Nr. | UNINA-9910787308103321 |
| Washington, District of Columbia : , : National Academies Press, , [2012] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Maximizing the impact of the Cures Acceleration Network : accelerating the development of new drugs and diagnostics : workshop summary / / Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
| Maximizing the impact of the Cures Acceleration Network : accelerating the development of new drugs and diagnostics : workshop summary / / Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies |
| Pubbl/distr/stampa | Washington, District of Columbia : , : National Academies Press, , [2012] |
| Descrizione fisica | 1 online resource (132 p.) |
| Disciplina | 615.1/9 |
| Soggetto topico |
Drug monitoring
Drug development - United States Drugs - United States - Design Pharmaceutical industry - United States - Quality control |
| ISBN |
0-309-26119-8
0-309-26117-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction [The history and goals of CAN (Cures Acceleration Network)] -- Approaches to accelerating translational science -- Application of matching authority -- Application of flexible research authority -- Situating CAN within the drug development ecosystem -- Final reflections on ways to maximize the goals of CAN. |
| Record Nr. | UNINA-9910826891403321 |
| Washington, District of Columbia : , : National Academies Press, , [2012] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pharmacovigilance . Volume 2 / / Charmy S. Kothari, editor
| Pharmacovigilance . Volume 2 / / Charmy S. Kothari, editor |
| Pubbl/distr/stampa | London : , : IntechOpen, , 2023 |
| Descrizione fisica | 1 online resource (124 pages) |
| Disciplina | 615.7 |
| Soggetto topico | Drug monitoring |
| ISBN | 1-80356-126-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910678588603321 |
| London : , : IntechOpen, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pharmacovigilance / / edited by Charmy S. Kothari
| Pharmacovigilance / / edited by Charmy S. Kothari |
| Pubbl/distr/stampa | London, United Kingdom : , : IntechOpen, , 2019 |
| Descrizione fisica | 1 online resource (88 pages) |
| Disciplina | 615.7042 |
| Soggetto topico |
Pharmacoepidemiology
Drugs - Side effects Drug monitoring |
| ISBN |
1-83962-084-6
1-78985-760-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910317956703321 |
| London, United Kingdom : , : IntechOpen, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pharmacovigilance medical writing [[electronic resource] ] : a good practice guide / / Justina Orleans-Lindsay
| Pharmacovigilance medical writing [[electronic resource] ] : a good practice guide / / Justina Orleans-Lindsay |
| Autore | Orleans-Lindsay Justina |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Chichester, West Sussex, U.K., : John Wiley & Sons Inc., 2012 |
| Descrizione fisica | 1 online resource (287 p.) |
| Disciplina |
615.4
615.7 615/.4 |
| Soggetto topico |
Drug monitoring
Communication in medicine - Methodology |
| ISBN |
1-118-30206-0
1-280-79269-8 9786613703088 1-118-30191-9 1-118-30190-0 1-118-30205-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Pharmacovigilance medical writing : an overview across the drug development process -- Pharmacovigilance medical writing for clinical trials -- Pharmacovigilance medical writing for CTD submissions -- Pharmacovigilance medical writing in risk evaluation & management -- Pharmacovigilance medical writing for marketed products -- The Ad-Hoc safety review & response to questions document -- The rest of the world. |
| Record Nr. | UNINA-9910141253603321 |
Orleans-Lindsay Justina
|
||
| Chichester, West Sussex, U.K., : John Wiley & Sons Inc., 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pharmacovigilance medical writing [[electronic resource] ] : a good practice guide / / Justina Orleans-Lindsay
| Pharmacovigilance medical writing [[electronic resource] ] : a good practice guide / / Justina Orleans-Lindsay |
| Autore | Orleans-Lindsay Justina |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Chichester, West Sussex, U.K., : John Wiley & Sons Inc., 2012 |
| Descrizione fisica | 1 online resource (287 p.) |
| Disciplina |
615.4
615.7 615/.4 |
| Soggetto topico |
Drug monitoring
Communication in medicine - Methodology |
| ISBN |
1-118-30206-0
1-280-79269-8 9786613703088 1-118-30191-9 1-118-30190-0 1-118-30205-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Pharmacovigilance medical writing : an overview across the drug development process -- Pharmacovigilance medical writing for clinical trials -- Pharmacovigilance medical writing for CTD submissions -- Pharmacovigilance medical writing in risk evaluation & management -- Pharmacovigilance medical writing for marketed products -- The Ad-Hoc safety review & response to questions document -- The rest of the world. |
| Record Nr. | UNINA-9910830636003321 |
|
Orleans-Lindsay Justina
|
||
| Chichester, West Sussex, U.K., : John Wiley & Sons Inc., 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pharmacovigilance medical writing [[electronic resource] ] : a good practice guide / / Justina Orleans-Lindsay
| Pharmacovigilance medical writing [[electronic resource] ] : a good practice guide / / Justina Orleans-Lindsay |
| Autore | Orleans-Lindsay Justina |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Chichester, West Sussex, U.K., : John Wiley & Sons Inc., 2012 |
| Descrizione fisica | 1 online resource (287 p.) |
| Disciplina |
615.4
615.7 615/.4 |
| Soggetto topico |
Drug monitoring
Communication in medicine - Methodology |
| ISBN |
1-118-30206-0
1-280-79269-8 9786613703088 1-118-30191-9 1-118-30190-0 1-118-30205-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Pharmacovigilance medical writing : an overview across the drug development process -- Pharmacovigilance medical writing for clinical trials -- Pharmacovigilance medical writing for CTD submissions -- Pharmacovigilance medical writing in risk evaluation & management -- Pharmacovigilance medical writing for marketed products -- The Ad-Hoc safety review & response to questions document -- The rest of the world. |
| Record Nr. | UNINA-9910840944003321 |
|
Orleans-Lindsay Justina
|
||
| Chichester, West Sussex, U.K., : John Wiley & Sons Inc., 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Post-authorization safety studies of medicinal products : the PASS book / / edited by Ayad K. Ali, Abraham G. Hartzema
| Post-authorization safety studies of medicinal products : the PASS book / / edited by Ayad K. Ali, Abraham G. Hartzema |
| Pubbl/distr/stampa | London, United Kingdom : , : Academic Press, , [2018] |
| Descrizione fisica | 1 online resource (364 pages) |
| Disciplina | 615.1901 |
| Soggetto topico |
Drugs - Testing
Drug monitoring |
| ISBN |
0-12-809208-4
0-12-809217-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910583333303321 |
| London, United Kingdom : , : Academic Press, , [2018] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
A practical handbook on the pharmacovigilance of antiretroviral medicines [[electronic resource] /] / World Health Organization
| A practical handbook on the pharmacovigilance of antiretroviral medicines [[electronic resource] /] / World Health Organization |
| Pubbl/distr/stampa | Geneva, : World Health Organization, c2009 |
| Descrizione fisica | 1 online resource (145 p.) |
| Disciplina | 616.97/92075 |
| Soggetto topico |
Antiretroviral agents
Drug monitoring |
| ISBN |
1-282-69718-8
9786612697180 92-4-068518-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | COVER; COPYRIGHT; Contents; Annexes; Glossary |
| Record Nr. | UNISA-996320232103316 |
| Geneva, : World Health Organization, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
